Hypopigmentation at injection site Subcutaneous fat atrophy at injection site Hypopigmentation Fat atrophy
Conditions
Interventions
0.5 ml of 10 mg/ml Triamcinolone acetonide injection + 0.5 ml of NSS + 1 ml of 1% Xylocaine without adrenaline (5mg)
Over 1st dorsal compartment,1 ml of 10 mg/ml Triamcinolone acetonide injection + 1
Experimental Drug,Active Comparator Drug
TA 5 mg,TA 10 mg
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age 18 to 80 years old 2. Diagnosed with De quervains tenosynovitis Finkelstein maneuver and Eichhoff maneuver 3. No history of Corticosteroid injection at 1st extensor compartment 4. Willing to join research after fully understand research protocol
Exclusion criteria
Exclusion criteria: 1. Allergic to Triamcinolone acetonide 2. Previous corticosteroid injection as treatment for De quervains tenosynovitis 3. Previous surgery for 1st extensor compartment release 4. Symptom persist more than 6 months 5. Scar or skin lesion over the wrist on radial side 6. CMC arthritis 7. Disability of the same extremity 8. Deformity of wrist on same side 9. History of distal end radius fracture on the same side
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue score Initially, 1, 3, 6 months 0 -10 | — |
Secondary
| Measure | Time frame |
|---|---|
| Thai DASH score Initially, 1, 3, 6 months 0 - 100,Complications 1,3,6 months Description ,Demographic Data of De Quervain's Tenosynovitis Initially Numerical, Description, Statistic | — |
Countries
Thailand
Contacts
Public ContactChesadakorn Thonglert
Faculty of Medicine Thammasat University
Outcome results
None listed